scai Weekly Update MultiBriefs
Contact Us
Media Kit

Browse Categories

Browse by Date

Search past issues
Search products and services

2021 MSCAI Recipients Recognized during the SCAI 2021 Scientific Sessions Virtual Conference

source: SCAI

Researchers sought to characterize the hemodynamic impact of mild coronary artery disease (CAD) using quantitative flow ratio (QFR, an angiography‐derived fractional flow reserve [FFR]) in a population of patients with only non‐significant CAD at baseline that...

source: Catheterization and Cardiovascular Interventions

The objective of this study is to identify and model risk factors for major adverse cardiac events and all‐cause mortality among patients with ESRD treated with PCI using DES. Patients...

source: Catheterization and Cardiovascular Interventions

Robotic-assisted percutaneous coronary intervention (PCI) procedures are safe and effective, according to new data presented April 29 at the Society for Cardiovascular Angiography & Interventions 2021 Scientific Sessions. Robotic-assisted...

source: Cardiovascular Business

The American Heart Association/American Stroke Association (AHA/ASA) has released guidance to help physicians respond to, and understand, the reports of rare blood clots and low platelet counts after COVID-19 vaccination.

source: TCTMD

The U.S. Food and Drug Administration has approved dapagliflozin (Farxiga; AstraZeneca) to reduce the risk of renal and cardiovascular adverse events in patients with chronic kidney disease (CKD) who are at risk of disease progression, irrespective of whether they have diabetes.

source: TCTMD


Powered by MultiBriefs
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063

Subscribe to SCAI This Week

*First Name:
*Last Name:
Street Address:
State / Province:
Zip / Postal Code:
Are you a member of SCAI? Yes   No
Privacy Policy